Dr. Krauss' research program focuses on plasma lipoprotein metabolism and related traits that influence risk for coronary artery disease. His laboratory developed and applied methodology that led to the discovery of a common genetically-influenced atherogenic lipoprotein phenotype that underlies cardiovascular disease risk in patients with obesity, type 2 diabetes, and metabolic syndrome. A major current research emphasis has been the identification of genetic determinants of the wide range of inter-individual variability in phenotypic and clinical response to statin treatment.
Dr. Krogan was born and raised in Regina, Saskatchewan, Canada, obtained his undergraduate degree from the University of Regina and his PhD from the University of Toronto. Dr. Krogan’s lab at UCSF focuses on developing and applying quantitative, systematic proteomic and genetic approaches to study complex biological and biomedical problems. At present time, the Krogan group is focused on studying cancer, infectious disease and psychiatric disorders.
I am an author and Associate Professor Medicine at the University of California, San Francisco, where I created and direct the adult inpatient bone marrow transplant massage service. I am dual board-certified in internal medicine and addiction medicine. I am faculty at the Osher Center for Integrative Health in San Francisco where I provide consultations in integrative oncology and integrative medicine, and I am chair of their educational case conference series. I teach the “Food as Medicine” CODA series for residents and students at the university.
Dr. Lai is a practicing general/transplant hepatologist and board-certified Physician Nutrition Specialist who specializes in caring for patients across the entire spectrum of liver disease, from diagnosis to liver transplant.
The translational research in my lab bridges basic and clinical investigation by engaging genomic technologies to understand relationships between microbes, host response and clinical outcomes. We study lower respiratory tract infections, ARDS, sepsis, nosocomial infections, and emerging pathogens including SARS-CoV-2. One focus area involves developing new diagnostic techniques that combine metagenomic sequencing and machine learning to simultaneously profile both host and microbiome from clinical samples.
Nooshin Navidi Latour heads communications for the Vice Chancellor Office for Science Policy and Strategy, UCSF Bakar Institute for Computational Health Sciences Institute (BCHSI) and UCSF Precision Medicine. She was formerly in charge of communications and marketing at the UCSF Clinical and Translational Science Institute (CTSI) for several years. Previously, Latour was at the Lucile Packard Foundation for Children's Health, Bay Area Video Coalition, think tank Next 10, The Japan Times, and a couple of early-stage startups.
Dr. Li works on human genomics. The main theme of his research is large-scale analysis of disease genomes by integrating multi-omics data, evolutionary insights, electronic health records, as well as digitized clinical traits from imaging and wearable sensor readouts. The ultimate goal is to build a data-driven framework to detect diseases before symptoms emerge and to achieve precision health management.
The Benioff Center for Microbiome Medicine (BCMM) stands committed to dismantling the structural barriers to education, research and employment endemic in our society, to promoting awareness of implicit bias and reinforcing inclusivity.